| http://dbpedia.org/ontology/abstract
|
Epitopoietic Research Corporation (ERC) is … Epitopoietic Research Corporation (ERC) is a Belgian Pharmaceutical company developing ERC1671 (brandnames: Gliovac, Sitoiganap (EU)), which specialise in treatment for Glioblastoma multiforme which is the most aggressive form of brain cancer. In 2019, ERC became the first pharmaceutical company to provide treatment under the US Federal Right-to-try law.ent under the US Federal Right-to-try law.
|
| http://dbpedia.org/ontology/foundingYear
|
2006
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/ontology/keyPerson
|
http://dbpedia.org/resource/Chief_executive_officer +
|
| http://dbpedia.org/ontology/product
|
http://dbpedia.org/resource/EU +
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Erc_Immunotherapy_logo.png?width=300 +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
http://www.erc-immunotherapy.com +
|
| http://dbpedia.org/ontology/wikiPageID
|
64559199
|
| http://dbpedia.org/ontology/wikiPageLength
|
19315
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1120863670
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Schaijk +
, http://dbpedia.org/resource/Compassionate_use +
, http://dbpedia.org/resource/Greece +
, http://dbpedia.org/resource/Phases_of_clinical_research +
, http://dbpedia.org/resource/Chief_executive_officer +
, http://dbpedia.org/resource/Neurosurgery +
, http://dbpedia.org/resource/Trump_Administration +
, http://dbpedia.org/resource/Abigail_Alliance +
, http://dbpedia.org/resource/FDA +
, http://dbpedia.org/resource/Athens +
, http://dbpedia.org/resource/Tumor +
, http://dbpedia.org/resource/Belgium +
, http://dbpedia.org/resource/File:AFIP-00405558-Glioblastoma-Radiology.jpg +
, http://dbpedia.org/resource/Innovation_Observatory +
, http://dbpedia.org/resource/Brain_cancer +
, http://dbpedia.org/resource/Good_manufacturing_practice +
, http://dbpedia.org/resource/Henry_Dunant +
, http://dbpedia.org/resource/Category:Belgian_companies_established_in_2006 +
, http://dbpedia.org/resource/Cytotoxic_T-lymphocyte +
, http://dbpedia.org/resource/Category:Orphan_drug_companies +
, http://dbpedia.org/resource/Bevacizumab +
, http://dbpedia.org/resource/European_Medicines_Agency +
, http://dbpedia.org/resource/Keck_School_of_Medicine_of_USC +
, http://dbpedia.org/resource/Harvard +
, http://dbpedia.org/resource/University_of_Li%C3%A8ge +
, http://dbpedia.org/resource/Right-to-try_law +
, http://dbpedia.org/resource/National_Health_Service +
, http://dbpedia.org/resource/University_of_Southern_California +
, http://dbpedia.org/resource/Category:Oncology +
, http://dbpedia.org/resource/Immune_system +
, http://dbpedia.org/resource/UK +
, http://dbpedia.org/resource/COVID-19 +
, http://dbpedia.org/resource/Netherlands +
, http://dbpedia.org/resource/University_of_California%2C_Irvine +
, http://dbpedia.org/resource/Orphan_Drug +
, http://dbpedia.org/resource/California +
, http://dbpedia.org/resource/EU +
, http://dbpedia.org/resource/Glioblastoma_multiforme +
, http://dbpedia.org/resource/Wageningen_University +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/File:Killer_T_cells_surround_a_cancer_cell.png +
, http://dbpedia.org/resource/Dana%E2%80%93Farber_Cancer_Institute +
|
| http://dbpedia.org/property/date
|
February 2021
|
| http://dbpedia.org/property/foundation
|
2006
|
| http://dbpedia.org/property/homepage
|
http://www.erc-immunotherapy.com +
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/property/keyPeople
|
Vince Dell
, Apostolos Stathopoulos
, Thomas Chen
, Virgil Schijns Joseph Elliot
|
| http://dbpedia.org/property/locationCity
|
http://dbpedia.org/resource/Belgium +
|
| http://dbpedia.org/property/logo
|
File:Erc_Immunotherapy_logo.png
|
| http://dbpedia.org/property/name
|
Epitopoietic Research Corporation
|
| http://dbpedia.org/property/products
|
ERC1671
|
| http://dbpedia.org/property/reason
|
the dark area at lower left quadrant, or the darkish area with white border straddling the upper/lower right quadrant, or maybe it is something else
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Advert +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Clarify +
, http://dbpedia.org/resource/Template:Reflist +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Orphan_drug_companies +
, http://dbpedia.org/resource/Category:Belgian_companies_established_in_2006 +
, http://dbpedia.org/resource/Category:Oncology +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Epitopoietic_Research_Corporation?oldid=1120863670&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/AFIP-00405558-Glioblastoma-Radiology.jpg +
, http://commons.wikimedia.org/wiki/Special:FilePath/Killer_T_cells_surround_a_cancer_cell.png +
, http://commons.wikimedia.org/wiki/Special:FilePath/Erc_Immunotherapy_logo.png +
|
| http://xmlns.com/foaf/0.1/homepage
|
http://www.erc-immunotherapy.com +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Epitopoietic_Research_Corporation +
|
| http://xmlns.com/foaf/0.1/name
|
Epitopoietic Research Corporation
|
| owl:sameAs |
http://dbpedia.org/resource/Epitopoietic_Research_Corporation +
, https://global.dbpedia.org/id/DACLu +
, http://www.wikidata.org/entity/Q97452934 +
|
| rdf:type |
http://www.wikidata.org/entity/Q24229398 +
, http://dbpedia.org/ontology/Agent +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://www.wikidata.org/entity/Q43229 +
, http://www.wikidata.org/entity/Q4830453 +
, http://schema.org/Organization +
, http://dbpedia.org/ontology/Company +
, http://dbpedia.org/ontology/Organisation +
|
| rdfs:comment |
Epitopoietic Research Corporation (ERC) is … Epitopoietic Research Corporation (ERC) is a Belgian Pharmaceutical company developing ERC1671 (brandnames: Gliovac, Sitoiganap (EU)), which specialise in treatment for Glioblastoma multiforme which is the most aggressive form of brain cancer. In 2019, ERC became the first pharmaceutical company to provide treatment under the US Federal Right-to-try law.ent under the US Federal Right-to-try law.
|
| rdfs:label |
Epitopoietic Research Corporation
|
